DK1820496T3 - Fremgangsmåde til fremstilling af en medicinsk anordning til implantering - Google Patents

Fremgangsmåde til fremstilling af en medicinsk anordning til implantering

Info

Publication number
DK1820496T3
DK1820496T3 DK07001576.3T DK07001576T DK1820496T3 DK 1820496 T3 DK1820496 T3 DK 1820496T3 DK 07001576 T DK07001576 T DK 07001576T DK 1820496 T3 DK1820496 T3 DK 1820496T3
Authority
DK
Denmark
Prior art keywords
stearate
palmitate
amikacin
tobramycin
gentamicin
Prior art date
Application number
DK07001576.3T
Other languages
English (en)
Inventor
Klaus-Dieter Dr Kuehn
Sebastian Dr Vogt
Original Assignee
Heraeus Kulzer Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heraeus Kulzer Gmbh filed Critical Heraeus Kulzer Gmbh
Application granted granted Critical
Publication of DK1820496T3 publication Critical patent/DK1820496T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Transplantation (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Physical Vapour Deposition (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Inorganic Insulating Materials (AREA)
DK07001576.3T 2006-02-15 2007-01-25 Fremgangsmåde til fremstilling af en medicinsk anordning til implantering DK1820496T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102006007245A DE102006007245A1 (de) 2006-02-15 2006-02-15 Implantatmaterial

Publications (1)

Publication Number Publication Date
DK1820496T3 true DK1820496T3 (da) 2012-01-23

Family

ID=37903579

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07001576.3T DK1820496T3 (da) 2006-02-15 2007-01-25 Fremgangsmåde til fremstilling af en medicinsk anordning til implantering

Country Status (14)

Country Link
US (1) US7858109B2 (da)
EP (1) EP1820496B1 (da)
JP (1) JP5226956B2 (da)
CN (1) CN101023926A (da)
AT (1) ATE527992T1 (da)
AU (1) AU2007200395B2 (da)
BR (1) BRPI0700273A (da)
CA (1) CA2570758C (da)
DE (1) DE102006007245A1 (da)
DK (1) DK1820496T3 (da)
ES (1) ES2374976T3 (da)
PL (1) PL1820496T3 (da)
PT (1) PT1820496E (da)
ZA (1) ZA200701306B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010020940B4 (de) * 2010-05-19 2014-09-25 Heraeus Medical Gmbh Antibiotische Beschichtung
EP2529763B1 (de) * 2011-06-03 2016-10-12 Waldemar Link GmbH & Co. KG Verfahren zum Herstellen einer Implantatbeschichtung und entsprechendes Implantat

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2320373B2 (de) 1973-04-21 1978-04-06 Merck Patent Gmbh, 6100 Darmstadt Antibioticahaltiges Mittel und seine Verwendung als chirurgisches Kunststoffmaterial
DE2651441C2 (de) 1976-11-11 1987-01-08 Merck Patent Gmbh, 6100 Darmstadt Antibioticahaltiges Mittel
DE3037270A1 (de) 1980-10-02 1982-05-19 Ulatowski, Lothar, Dr.med., 5630 Remscheid Fibrinantibiotikumverbundketten
DE4404018A1 (de) * 1994-02-09 1995-08-10 Merck Patent Gmbh Protrahiert freisetzende Darreichungsformen enthaltend Clindamycin-Palmitat
SE9401169L (sv) * 1994-04-08 1995-10-09 Corimed Gmbh Förfarande för framställning av ett antibekteriellt aktivt ämne samt användning därav
US5756127A (en) * 1996-10-29 1998-05-26 Wright Medical Technology, Inc. Implantable bioresorbable string of calcium sulfate beads
DE10114244A1 (de) 2001-03-22 2002-10-02 Heraeus Kulzer Gmbh & Co Kg Antibiotikum-/Antibiotika-Zubereitung mit retardierender Wirkstofffreisetzung
DE10114364A1 (de) 2001-03-22 2002-10-02 Heraeus Kulzer Gmbh & Co Kg Verfahren zur Herstellung von antibiotischen Kompositen
CA2451187C (en) * 2001-06-22 2012-08-14 Southern Biosystems, Inc. Zero-order prolonged release coaxial implants
US6648849B2 (en) * 2001-06-27 2003-11-18 Ethicon, Inc. Medicinal implant and device and method for loading and delivering implants containing drugs and cells
DE10262176B4 (de) 2002-06-21 2007-10-04 Heraeus Kulzer Gmbh Verfahren zur Herstellung von antibiotisch beschichteten porösen Körpern sowie Verwendung
US7393687B2 (en) * 2004-07-16 2008-07-01 William Marsh Rice University Biomimetic 3-dimensional scaffold with metabolic stream separation for bioartificial liver device

Also Published As

Publication number Publication date
PL1820496T3 (pl) 2012-03-30
ES2374976T3 (es) 2012-02-23
US20070190109A1 (en) 2007-08-16
BRPI0700273A (pt) 2007-11-06
PT1820496E (pt) 2012-01-13
JP5226956B2 (ja) 2013-07-03
EP1820496A3 (de) 2008-07-09
ATE527992T1 (de) 2011-10-15
JP2007217413A (ja) 2007-08-30
EP1820496B1 (de) 2011-10-12
CA2570758C (en) 2011-07-19
AU2007200395B2 (en) 2007-11-29
CA2570758A1 (en) 2007-08-15
CN101023926A (zh) 2007-08-29
EP1820496A2 (de) 2007-08-22
ZA200701306B (en) 2008-07-30
DE102006007245A1 (de) 2007-08-23
US7858109B2 (en) 2010-12-28
AU2007200395A1 (en) 2007-08-30

Similar Documents

Publication Publication Date Title
IL186452A0 (en) Methods and means for diagnostics, prevention and treatment of mycobacterium infections and tuberculosis disease
WO2008137237A3 (en) Method for forming crystallized therapeutic agents on a medical device
BRPI0719899A2 (pt) método e dispositivo para montar quadros de correção antecipada de erros em fluxo contínuo de multimídia.
EA201000383A1 (ru) Способ ингибирования клостридиум диффициле введением оритаванцина
BRPI0815057A2 (pt) Composto, composição farmacêutica, e, método para tratar infecção.
BRPI0816346A2 (pt) método para randomizar a interferência experimentada por um canal de controle compartilhado, e, estação base de rádio
WO2007118130A3 (en) Antibacterial agents
WO2006081182A3 (en) Antibacterial agents
DE602006019754D1 (de) Verfahren und zusammensetzung, die immunomodulatorische verbindungen zur behandlung von mit niedrigen plasmaleptin-spiegeln in zusammenhang stehenden störungen verwenden
WO2006081178A3 (en) Antibacterial agents
BR0213398A (pt) Sal de alendronato, alendronato monossódico, processos para a produção dos mesmos, composição farmacêutica, e, método para inibição da ressorção óssea em um paciente
WO2010065735A3 (en) Methods and compositions for treating p.acnes
DK1820496T3 (da) Fremgangsmåde til fremstilling af en medicinsk anordning til implantering
BR0213154A (pt) Compostos de glicopeptìdeo - cefalosporina de ligação reticulada, composições farmacêuticas de tais compostos, método de fabricação dos mesmos e seus usos
BR0301708A (pt) Preparação farmacêutica com liberação de substância ativas retardada, processo para produção e uso da mesma
HK1115528A1 (en) Combination of pyrimidylaminobenzamide compounds and imatinib for treating or preventing proliferative diseases
BRPI0810192A2 (pt) Aspartato do ácido 1-ciclopropil-6-fluoro-7-(8-metoxiimino-2,6-diazaespir o [3,4] oct-6-il)-4-oxo-1,4-diidro- [1,8] naftiridina-3-carboxílico, método para preparação do mesmo e composição farmacêutica antimicrobiana compreendendo o mesmo.
BRPI0511262A (pt) combinação de compostos orgánicos
WO2007116029A3 (en) Combination comprising a) a pyrimidylaminobenzamide compound, and b) a thr315lle kinase inhibitor
WO2007010013A3 (en) Combination comprising a pyrimidylaminobenzamides and a flt-3 inhibitor for treating proliferative diseases
ATE449102T1 (de) Kristallines azithromycin-l-malat-monohydrat und pharmazeutische zusammensetzung, die dieses enthält
WO2007010012A3 (en) Combination of a pyrimidylaminobenzamide and an mtor kinase inhibitor
WO2007092930A3 (en) Method of treatment for mycobacterium tuberculosis
WO2006021893A3 (en) Pharmaceutical compositions comprising inhibitors of iron transport, and method of identifying iron transport inhibitors, fn staphylococcus aureus
BRPI0401802B1 (pt) composiÇço aquosa de tratamento de couro, mÉtodo para preparar um substrato de couro revestido por gravaÇço em relevo, e, substrato de couro revestido por gravaÇço em relevo.